Using immunonutrition to improve recovery in gynecologic cancer surgery
Immunonutrition and Enhanced Recovery After Surgery Protocols in Gynecologic Oncology
This study is testing if special nutritional support before and after surgery can help women recovering from gynecologic cancer surgery feel better and heal faster.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 20 Years to 80 Years |
| Sex | Female |
| Sponsor | National and Kapodistrian University of Athens Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Athens) |
| Trial ID | NCT06103526 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of perioperative immunonutrition supplementation on postoperative outcomes in women undergoing surgery for gynecologic malignancies. It addresses the issue of malnutrition, which can complicate recovery and affect the efficacy of subsequent cancer treatments. The study aims to identify which patients benefit most from enteral immunonutrition by analyzing real-time data on their postoperative recovery. By focusing on nutritional support, the study seeks to enhance the overall treatment protocol for these patients.
Who should consider this trial
Good fit: Ideal candidates are women with any gynecologic malignancy who are scheduled for surgery and can consume oral supplements.
Not a fit: Patients unable to follow the Enhanced Recovery After Surgery (ERAS) protocol due to medical reasons or those with severe diseases that prevent compliance may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve recovery times and overall outcomes for patients undergoing surgery for gynecologic cancers.
How similar studies have performed: Other studies have shown promising results with immunonutrition in surgical patients, indicating potential benefits in recovery and treatment efficacy.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * women with any gynaecologic malignancy enrolled in surgical list of our institute * must be able to consume oral supplements. Exclusion Criteria: * women that are not able to follow ERAS protocol due to medical reasons * patients with severe disease that cannot compromise with protocol
Where this trial is running
Athens
- First department of Obstetrics and Gynecology — Athens, Greece (Recruiting)
Study contacts
- Study coordinator: Nikolaos Thomakos, MD
- Email: thomakir@hotmail.com
- Phone: +302132162291
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.